38128-83-5 Usage
General Description
(8Z,24E)-8-[(butoxyamino)methylidene]-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is a complex compound with a long name. It is a synthetic chemical that belongs to the class of organic compounds known as naphthoquinones. (8Z,24E)-8-[(butoxyamino)methylidene]-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is a derivative of naphthoquinone and acetate, and it contains multiple functional groups including hydroxy, methoxy, epoxide, and acetate groups. The unique molecular structure and multiple functional groups make this compound potentially useful in various chemical and pharmaceutical applications, though further research and testing would be needed to determine its specific uses.
Check Digit Verification of cas no
The CAS Registry Mumber 38128-83-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,1,2 and 8 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 38128-83:
(7*3)+(6*8)+(5*1)+(4*2)+(3*8)+(2*8)+(1*3)=125
125 % 10 = 5
So 38128-83-5 is a valid CAS Registry Number.
38128-83-5Relevant articles and documents
Oximes of 3 formylrifamycin SV. Synthesis, antibacterial activity, and other biological properties
Cricchio,Lancini,Tamborini,Sensi
, p. 396 - 403 (2007/10/06)
The synthesis of the oximes of 3 formylrifamycin SV and the preparation of some of the O substituted hydroxylamine intermediates are described. The chemical and physical characteristics, the antibacterial activity on wild type and rifampicin resistant strains, and other biological properties of the new derivatives are reported. Structure activity relationships show that increasing the lipophilicity of the oxime substituent decreases the antibacterial activity, both in vitro and in experimental infection, whereas inhibition of a rifampicin resistant strain of S. aureus and of several transcribing enzymes is increased.
